Coronary restenosis after drug-eluting stent implantation in diabetic patients

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

In the era of drug-eluting stents (DESs), the angiographic rates of restenosis at later months have been dramatically reduced, but these rates have been less prominently reduced in diabetic patients. The rate of coronary restenosis is still higher in diabetic patients, when compared with non-diabetic patients, and even after DES implantation. Diabetes remains a significant predictor of coronary restenosis even in the era of DES, and especially in cases having a small baseline vessel size, a small post-PCI vessel size and a longer stent length. The use of the sirolimus-eluting stent in diabetic patients has been associated with a decreased rate of restenosis, and this suggests a reduced risk of target lesion revascularization. Diabetes still remains a major risk factor for coronary restenosis after DES implantation, and so aggressive risk factor management with the concomitant pharmacotherapy should be done to reduce the risk of coronary restenosis.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalKorean Circulation Journal
Volume36
Issue number1
Publication statusPublished - 2006 Jan 1

Fingerprint

Coronary Restenosis
Drug-Eluting Stents
Stents
Risk Management
Sirolimus
Drug Therapy

Keywords

  • Coronary restenosis
  • Diabetes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine

Cite this

Coronary restenosis after drug-eluting stent implantation in diabetic patients. / Lim, Do-Sun.

In: Korean Circulation Journal, Vol. 36, No. 1, 01.01.2006, p. 1-7.

Research output: Contribution to journalArticle

@article{f3c2ef160de34ccebad49cfe3065e6b1,
title = "Coronary restenosis after drug-eluting stent implantation in diabetic patients",
abstract = "In the era of drug-eluting stents (DESs), the angiographic rates of restenosis at later months have been dramatically reduced, but these rates have been less prominently reduced in diabetic patients. The rate of coronary restenosis is still higher in diabetic patients, when compared with non-diabetic patients, and even after DES implantation. Diabetes remains a significant predictor of coronary restenosis even in the era of DES, and especially in cases having a small baseline vessel size, a small post-PCI vessel size and a longer stent length. The use of the sirolimus-eluting stent in diabetic patients has been associated with a decreased rate of restenosis, and this suggests a reduced risk of target lesion revascularization. Diabetes still remains a major risk factor for coronary restenosis after DES implantation, and so aggressive risk factor management with the concomitant pharmacotherapy should be done to reduce the risk of coronary restenosis.",
keywords = "Coronary restenosis, Diabetes",
author = "Do-Sun Lim",
year = "2006",
month = "1",
day = "1",
language = "English",
volume = "36",
pages = "1--7",
journal = "Korean Circulation Journal",
issn = "1738-5520",
publisher = "Korean Society of Circulation",
number = "1",

}

TY - JOUR

T1 - Coronary restenosis after drug-eluting stent implantation in diabetic patients

AU - Lim, Do-Sun

PY - 2006/1/1

Y1 - 2006/1/1

N2 - In the era of drug-eluting stents (DESs), the angiographic rates of restenosis at later months have been dramatically reduced, but these rates have been less prominently reduced in diabetic patients. The rate of coronary restenosis is still higher in diabetic patients, when compared with non-diabetic patients, and even after DES implantation. Diabetes remains a significant predictor of coronary restenosis even in the era of DES, and especially in cases having a small baseline vessel size, a small post-PCI vessel size and a longer stent length. The use of the sirolimus-eluting stent in diabetic patients has been associated with a decreased rate of restenosis, and this suggests a reduced risk of target lesion revascularization. Diabetes still remains a major risk factor for coronary restenosis after DES implantation, and so aggressive risk factor management with the concomitant pharmacotherapy should be done to reduce the risk of coronary restenosis.

AB - In the era of drug-eluting stents (DESs), the angiographic rates of restenosis at later months have been dramatically reduced, but these rates have been less prominently reduced in diabetic patients. The rate of coronary restenosis is still higher in diabetic patients, when compared with non-diabetic patients, and even after DES implantation. Diabetes remains a significant predictor of coronary restenosis even in the era of DES, and especially in cases having a small baseline vessel size, a small post-PCI vessel size and a longer stent length. The use of the sirolimus-eluting stent in diabetic patients has been associated with a decreased rate of restenosis, and this suggests a reduced risk of target lesion revascularization. Diabetes still remains a major risk factor for coronary restenosis after DES implantation, and so aggressive risk factor management with the concomitant pharmacotherapy should be done to reduce the risk of coronary restenosis.

KW - Coronary restenosis

KW - Diabetes

UR - http://www.scopus.com/inward/record.url?scp=33644583478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644583478&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33644583478

VL - 36

SP - 1

EP - 7

JO - Korean Circulation Journal

JF - Korean Circulation Journal

SN - 1738-5520

IS - 1

ER -